1. Home
  2. MYSZ vs KZIA Comparison

MYSZ vs KZIA Comparison

Compare MYSZ & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYSZ
  • KZIA
  • Stock Information
  • Founded
  • MYSZ 1999
  • KZIA 1994
  • Country
  • MYSZ Israel
  • KZIA Australia
  • Employees
  • MYSZ N/A
  • KZIA N/A
  • Industry
  • MYSZ Computer Software: Prepackaged Software
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYSZ Technology
  • KZIA Health Care
  • Exchange
  • MYSZ Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • MYSZ 8.2M
  • KZIA 6.0M
  • IPO Year
  • MYSZ N/A
  • KZIA 1999
  • Fundamental
  • Price
  • MYSZ $1.76
  • KZIA $0.98
  • Analyst Decision
  • MYSZ Strong Buy
  • KZIA Strong Buy
  • Analyst Count
  • MYSZ 1
  • KZIA 2
  • Target Price
  • MYSZ $3.00
  • KZIA $11.50
  • AVG Volume (30 Days)
  • MYSZ 178.4K
  • KZIA 5.5M
  • Earning Date
  • MYSZ 03-31-2025
  • KZIA 03-26-2025
  • Dividend Yield
  • MYSZ N/A
  • KZIA N/A
  • EPS Growth
  • MYSZ N/A
  • KZIA N/A
  • EPS
  • MYSZ N/A
  • KZIA N/A
  • Revenue
  • MYSZ $9,632,000.00
  • KZIA $1,655,324.00
  • Revenue This Year
  • MYSZ $35.62
  • KZIA $806.89
  • Revenue Next Year
  • MYSZ $12.88
  • KZIA N/A
  • P/E Ratio
  • MYSZ N/A
  • KZIA N/A
  • Revenue Growth
  • MYSZ 43.89
  • KZIA 248000.00
  • 52 Week Low
  • MYSZ $1.05
  • KZIA $0.91
  • 52 Week High
  • MYSZ $9.40
  • KZIA $15.80
  • Technical
  • Relative Strength Index (RSI)
  • MYSZ 40.63
  • KZIA 30.47
  • Support Level
  • MYSZ $1.88
  • KZIA $1.31
  • Resistance Level
  • MYSZ $2.30
  • KZIA $1.60
  • Average True Range (ATR)
  • MYSZ 0.19
  • KZIA 0.27
  • MACD
  • MYSZ -0.03
  • KZIA 0.02
  • Stochastic Oscillator
  • MYSZ 9.24
  • KZIA 4.11

About MYSZ My Size Inc.

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: